PET/CT-guided treatment planning for paediatric cancer patients : A simulation study of proton and conventional photon therapy
(2015) In British Journal of Radiology 88(1047).- Abstract
Objective: To investigate the impact of including fluorine-18 fludeoxyglucose (18F-FDG) positron emission tomography (PET) scanning in the planning of paediatric radiotherapy (RT). Methods: Target volumes were first delineated without and subsequently re-delineated with access to 18F-FDG PET scan information, on duplicate CT sets. RT plans were generated for three-dimensional conformal photon RT (3DCRT) and intensity-modulated proton therapy (IMPT). The results were evaluated by comparison of target volumes, target dose coverage parameters, normal tissue complication probability (NTCP) and estimated risk of secondary cancer (SC). Results: Considerable deviations between CT-and PET/CT-guided target volumes were seen... (More)
Objective: To investigate the impact of including fluorine-18 fludeoxyglucose (18F-FDG) positron emission tomography (PET) scanning in the planning of paediatric radiotherapy (RT). Methods: Target volumes were first delineated without and subsequently re-delineated with access to 18F-FDG PET scan information, on duplicate CT sets. RT plans were generated for three-dimensional conformal photon RT (3DCRT) and intensity-modulated proton therapy (IMPT). The results were evaluated by comparison of target volumes, target dose coverage parameters, normal tissue complication probability (NTCP) and estimated risk of secondary cancer (SC). Results: Considerable deviations between CT-and PET/CT-guided target volumes were seen in 3 out of the 11 patients studied. However, averaging over the whole cohort, CT or PET/CT guidance introduced no significant difference in the shape or size of the target volumes, target dose coverage, irradiated volumes, estimated NTCP or SC risk, neither for IMPT nor 3DCRT. Conclusion: Our results imply that the inclusion of PET/CT scans in the RT planning process could have considerable impact for individual patients. There were no general trends of increasing or decreasing irradiated volumes, suggesting that the long-term morbidity of RT in childhood would on average remain largely unaffected. Advances in knowledge: 18F-FDG PET-based RT planning does not systematically change NTCP or SC risk for paediatric cancer patients compared with CT only. 3 out of 11 patients had a distinct change of target volumes when PET-guided planning was introduced. Dice and mismatch metrics are not sufficient to assess the consequences of target volume differences in the context of RT.
(Less)
- author
- Kornerup, Josefine Ståhl ; Brodin, N. P. ; Björk-Eriksson, T. ; Birk Christensen, C. ; Kiil-Berthelsen, A. ; Aznar, M. C. ; Hollensen, C. ; Markova, E. and Munck Af Rosenschöld, P. LU
- publishing date
- 2015-03-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- British Journal of Radiology
- volume
- 88
- issue
- 1047
- article number
- 20140586
- publisher
- British Institute of Radiology
- external identifiers
-
- pmid:25494657
- scopus:84923480339
- ISSN
- 0007-1285
- DOI
- 10.1259/bjr.20140586
- language
- English
- LU publication?
- no
- additional info
- Publisher Copyright: © 2015 The Authors. Published by the British Institute of Radiology.
- id
- b1269cb5-1470-4315-8927-d98e58c76c45
- date added to LUP
- 2023-07-19 17:01:50
- date last changed
- 2024-01-05 03:31:27
@article{b1269cb5-1470-4315-8927-d98e58c76c45, abstract = {{<p>Objective: To investigate the impact of including fluorine-18 fludeoxyglucose (<sub>18</sub>F-FDG) positron emission tomography (PET) scanning in the planning of paediatric radiotherapy (RT). Methods: Target volumes were first delineated without and subsequently re-delineated with access to <sub>18</sub>F-FDG PET scan information, on duplicate CT sets. RT plans were generated for three-dimensional conformal photon RT (3DCRT) and intensity-modulated proton therapy (IMPT). The results were evaluated by comparison of target volumes, target dose coverage parameters, normal tissue complication probability (NTCP) and estimated risk of secondary cancer (SC). Results: Considerable deviations between CT-and PET/CT-guided target volumes were seen in 3 out of the 11 patients studied. However, averaging over the whole cohort, CT or PET/CT guidance introduced no significant difference in the shape or size of the target volumes, target dose coverage, irradiated volumes, estimated NTCP or SC risk, neither for IMPT nor 3DCRT. Conclusion: Our results imply that the inclusion of PET/CT scans in the RT planning process could have considerable impact for individual patients. There were no general trends of increasing or decreasing irradiated volumes, suggesting that the long-term morbidity of RT in childhood would on average remain largely unaffected. Advances in knowledge: <sub>18</sub>F-FDG PET-based RT planning does not systematically change NTCP or SC risk for paediatric cancer patients compared with CT only. 3 out of 11 patients had a distinct change of target volumes when PET-guided planning was introduced. Dice and mismatch metrics are not sufficient to assess the consequences of target volume differences in the context of RT.</p>}}, author = {{Kornerup, Josefine Ståhl and Brodin, N. P. and Björk-Eriksson, T. and Birk Christensen, C. and Kiil-Berthelsen, A. and Aznar, M. C. and Hollensen, C. and Markova, E. and Munck Af Rosenschöld, P.}}, issn = {{0007-1285}}, language = {{eng}}, month = {{03}}, number = {{1047}}, publisher = {{British Institute of Radiology}}, series = {{British Journal of Radiology}}, title = {{PET/CT-guided treatment planning for paediatric cancer patients : A simulation study of proton and conventional photon therapy}}, url = {{http://dx.doi.org/10.1259/bjr.20140586}}, doi = {{10.1259/bjr.20140586}}, volume = {{88}}, year = {{2015}}, }